(6.) Jonathan Kahn, Race in a Bottle: The Story of BiDil
and Racialized Medicine in a Post-Genomic Age 21, 90 (Columbia Univ.
: Assessing a Race-Based Pharmaceutical, 4 Ann.
My discussion of BiDil
seeks to reframe the disparity in incidence of heart disease--a problem that is too often moralized and technologized--as a social and political problem by focusing on the ways in which science and technology produce material shifts that become intelligible through narratives and social discourses that appear as inevitable discoveries rather than as components of larger political projects.
Stockbridge, supra note 141, at 57-61 (defending FDA approval of BiDil
The search term "BiDil
" yielded 167 articles in total, of which 105 were accepted for inclusion.
: Race Medicine or Race Marketing?" Health Affairs, W5-455 to W5-463, 2005.
"Two large heart failure studies using two distinct formulations showed different results in decreasing mortality, only BiDil
has shown significant reductions in death and hospitalization in black heart failure patients, as seen in A-HeFT.
Some experts have concluded that a good response to BiDil
has more to do with attributes and genes than it does with racial identity.
One example of a medicine targeted at racial categories is BiDil
(fixed-dose isosorbide dinitrate and hydralazine), a heart failure drug that was approved specifically for use in blacks.
Despite the truism that biological race does not exist, in recent decades we have seen significant growth in race-based research (see Abraham, 2005), racial genetic counselling and testing (e.g., Myriad Genetics Laboratories' recent success at obtaining a patent for their Ashkenazi-specific [BRCA.sub.2] test), and even race-specific pharmaceuticals (e.g., BiDil
The manufacturers of this new drug, BiDil
, believe there must also be some that work better for blacks.
Morever, Nebivolol, a beta-blocker drug currently under review at the Food and Drug Administration (FDA) has shown promise in reducing hypertension in African American patients and BiDil
(combination of isisorbide dinitrate and hydralize) has recently been approved as a heart failure medication for African Americans.